Treatment Registry
TR-0141 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Heva Health · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$339

Medication · Tirzepatide, any dose, month-to-month$339

Added from the figures recorded below.

Price

TermPer monthCharged today
Tirzepatide, any dose, month-to-month

$339/month Any dose — same price Virtual doctor consult, prescription medication, supplies, overnight shipping. No insurance required.

source

Per month$339Charged today$339
Tirzepatide, 3-Month Program

3-Month Program Most Popular Save 15 % Billed monthly · 3 payments $399 /mo $339 /mo

source

Per month$339Charged today$339
Visit Heva Health

We earn nothing from this link. Heva Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

Cancellation“Cancel or pause subscription”

Not yet checked: pharmacy, states, prescriber, membership and consult fee.

Recorded from hevahealth.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The /weight-loss page's nav toggles between a 'Semaglutide' and 'Tirzepatide' tab, but only the Tirzepatide tab's content and price rendered in static HTML (the page loaded as 'Home / Weight Loss / Tirzepatide'); /weight-loss/semaglutide 404'd, so no semaglutide price could be recorded despite the drug clearly being offered in the same UI. Separately, Heva's other (non-GLP-1) 'Full-Service Care' track is listed as available only in AZ, CO, CT, FL, IA, ID, NV, NY, UT, VA, WA, WY, while the GLP-1 'Direct Access' track is 'Available nationwide' — the AK/AR/IN/MN/SC exclusion above is the only concrete state restriction found specific to Tirzepatide itself.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0141
Readings
1

Related records

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Heva Health compounded tirzepatide (TR-0141). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0141

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.